Compass Consulting

When a drug development accelerator needed to scale quality systems for multiple gene therapy programs, they turned to Compass. Read our latest case study and learn how our strategic placement of a Senior Director of Quality Assurance transformed our client’s IND-enabling capabilities and positioned them for continued growth. https://lnkd.in/eWm3j2Vq #QualityAssurance #INDEnablingPhase #LifeSciencesStaffing #PlacementSuccess #Compass

We're always thrilled to see companies focused on life-changing therapies for people with rare diseases. That's why we were so excited to see Astria Therapeutics, Inc.' news regarding the design of their ALPHA-ORBIT pivotal Phase 3 trial for navenibart for treating hereditary angioedema (HAE). For patients living with HAE, navenibart represents a potential breakthrough in treatment. This could mean giving patients the freedom to live their lives with fewer injections while still experiencing significant protection from painful and potentially life-threatening HAE attacks. Early trials showed an impressive 90-95% reduction in monthly attack rates We look forward to following the progress of the ALPHA-ORBIT trial. Read more here: https://lnkd.in/eYhS_mxM #BiotechInnovation #RareDisease #ClinicalTrials

The hidden costs of unfilled positions extend far beyond recruitment fees. Our latest analysis reveals how hiring delays impact development timelines, market position, and bottom line. Read the full insights: https://lnkd.in/ehWcSR8x

We’re hiring a Research Associate in cell therapy! Are you passionate about advancing cell therapy and making a real impact in biotech? A leading company in South San Francisco, CA is looking for a Research Associate to join their innovative team. Key Responsibilities: ?? Conduct cutting-edge research in cell therapy ?? Perform cell culture, molecular biology, and analytical assays ?? Collaborate with top scientists in the field ?? Location: South San Francisco, CA ?? Apply now: https://lnkd.in/e7qJjtyC #BiotechCareers #CellTherapy #ResearchAssociate #HiringNow #LifeSciences #CompassJobs

Raising a virtual toast to Jessie Thomas on her birthday! Your hard work and positive energy inspire us all. May this year bring you incredible opportunities and unforgettable memories. Happy birthday! ??

When every day counts in drug development, you need a staffing partner who understands the urgency. Book a meeting to discuss your critical hiring needs and discover how we cut placement times by 60%: https://lnkd.in/eA2WCD3d

When timelines are tight and expertise is crucial, life sciences organizations turn to embedded consultants. We help organizations connect with expert biopharma consultants in clinical development and regulatory affairs who are accelerating breakthrough discoveries while maximizing resource efficiency. https://lnkd.in/dRMAtCGW #LifeSciencesConsulting #BiotechTalent

We're hiring a Scientist I – Biomarker Strategy in San Rafael, CA. Are you passionate about biomarker discovery and translational research? Join a cutting-edge team in San Rafael, CA and play a key role in advancing therapies for rare diseases! What You’ll Do: ?? Develop and implement biomarker strategies ?? Collaborate with cross-functional teams in drug development ?? Work with state-of-the-art platforms for biomarker discovery Ideal Candidate: ?? PhD or MS in Biology, Biochemistry, or related field ?? Experience in biomarker discovery & translational research ?? Strong analytical & problem-solving skills Apply now: https://lnkd.in/d8DhzxUM #BiomarkerStrategy #BiotechJobs #HiringNow #ScientistJobs #LifeSciences #CompassJobs

Speed matters in rare disease research. We recently partnered with a leading biotech company facing expertise gaps during IND-enabling studies for their gene therapy program. Compass stepped in, placing a VP of Nonclinical Development and Bioanalytical Scientist who streamlined CRO collaboration and accelerated development. See how strategic talent delivered when science couldn't wait ?? https://lnkd.in/eMJRNy9J #VPOfNonclinicalDevelopment #INDEnablingStudies #PlacementSuccess

Breaking news from Amgen! FDA approves LUMAKRAS? in combination with Vectibix? for KRAS G12C-mutated metastatic colorectal cancer. This groundbreaking targeted therapy doubled progression-free survival compared to standard care, offering new hope for patients with this challenging cancer type. This approval marks a significant advance in precision medicine for colorectal cancer, the third leading cause of cancer-related deaths in the US. Congratulations to the Amgen team for their continued innovation in developing treatments that address critical unmet needs in oncology! Learn more: https://lnkd.in/eJphZ-cm #PrecisionOncology #ColorectalCancer #BiotechInnovation